# How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.

> **NCT07289724** · — · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 57 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** Focus group
- **OTHER:** individual interview

## Key facts

- **NCT ID:** NCT07289724
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07289724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07289724, "How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07289724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*